First reported use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) system in Europe–A feasibility trial, surgical guide and review for non-palpable …
W Malter, J Holtschmidt, F Thangarajah, P Mallmann… - in vivo, 2019 - iv.iiarjournals.org
Background/Aim: The problem of adequately marking any given lesion within a breast
surgical site is commonly solved by introducing a titanium clip. However, clip dislocation …
surgical site is commonly solved by introducing a titanium clip. However, clip dislocation …
The LOCalizer radiofrequency identification system: An effective new technology for localizing non-palpable breast lesions for surgery
CM Cullinane, J Byrne, L Akmenkalne… - Surgical …, 2021 - journals.sagepub.com
Background. Breast screening has decreased morbidity and mortality due to detection of
early, non-palpable breast cancers. One of the challenges of performing breast-conserving …
early, non-palpable breast cancers. One of the challenges of performing breast-conserving …
[HTML][HTML] A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and …
BM den Dekker, A Christenhusz, T van Dalen… - BMC cancer, 2022 - Springer
Background Breast cancer screening and improving imaging techniques have led to an
increase in the detection rate of early, nonpalpable breast cancers. For early breast cancer …
increase in the detection rate of early, nonpalpable breast cancers. For early breast cancer …
[HTML][HTML] Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety
A Christenhusz, BM den Dekker, T van Dalen… - Breast cancer research …, 2023 - Springer
Purpose In breast conserving surgery, accurate lesion localization is essential for obtaining
adequate surgical margins. Preoperative wire localization (WL) and radioactive seed …
adequate surgical margins. Preoperative wire localization (WL) and radioactive seed …
Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK …
S Lowes, A Bell, R Milligan, S Amonkar, A Leaver - Clinical Radiology, 2020 - Elsevier
AIM To report the outcome of 150 patients using the Hologic LOCalizer RFID
(radiofrequency identification) tag system, including the first reported use of RFID tags in the …
(radiofrequency identification) tag system, including the first reported use of RFID tags in the …
Retrospective review of preoperative radiofrequency tag localization of breast lesions in 848 patients
LR Lamb, L Gilman, M Specht… - American Journal of …, 2021 - Am Roentgen Ray Soc
Please see the Editorial Comment by Sally H. Goudreau discussing this article.
BACKGROUND. Advantages of radiofrequency tags for preoperative breast lesion …
BACKGROUND. Advantages of radiofrequency tags for preoperative breast lesion …
[HTML][HTML] The evolving role of radiofrequency guided localisation in breast surgery: a systematic review
Simple Summary A large portion of breast lesions are not palpable and need to be marked
before surgery in order to aid complete surgical removal. Currently, this is accomplished by …
before surgery in order to aid complete surgical removal. Currently, this is accomplished by …
Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery
Purpose Use of a wire to localize a non-palpable breast lesion for surgery is standard but
archaic. We sought to evaluate a new radiofrequency localization system (RFLS) as an …
archaic. We sought to evaluate a new radiofrequency localization system (RFLS) as an …
Evaluation of a Wireless Localization System for Nonpalpable Breast Lesions—Feasibility and Cost-effectiveness in Everyday Clinical Routine
F Heindl, R Schulz-Wendtland, S Jud, R Erber… - in vivo, 2022 - iv.iiarjournals.org
Abstract Background/Aim: Smaller, earlier-stage breast tumors are being found in breast
cancer screening, and neoadjuvant chemotherapy is the gold standard when chemotherapy …
cancer screening, and neoadjuvant chemotherapy is the gold standard when chemotherapy …
[PDF][PDF] Radio-frequency identifier devices (RFIDs): our experience with wireless localisation in non-palpable breast masses at a UK tertiary breast imaging unit
C Singh, A Juette - Cureus, 2022 - cureus.com
The aim of this report is to evaluate the impact of the percutaneous ultrasound-guided
placement of wireless radio-frequency identifier devices (RFIDs; Hologic LOCalizer …
placement of wireless radio-frequency identifier devices (RFIDs; Hologic LOCalizer …